KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Common Equity (2016 - 2026)

Lam Research has reported Common Equity over the past 18 years, most recently at $10.6 billion for Q1 2026.

  • Quarterly Common Equity rose 11.29% to $10.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $10.6 billion through Mar 2026, up 11.29% year-over-year, with the annual reading at $9.9 billion for FY2025, 15.48% up from the prior year.
  • Common Equity was $10.6 billion for Q1 2026 at Lam Research, up from $10.1 billion in the prior quarter.
  • Over five years, Common Equity peaked at $10.6 billion in Q1 2026 and troughed at $6.0 billion in Q1 2022.
  • The 5-year median for Common Equity is $8.4 billion (2023), against an average of $8.5 billion.
  • Biggest five-year swings in Common Equity: skyrocketed 39.51% in 2023 and later dropped 4.58% in 2024.
  • Tracing LRCX's Common Equity over 5 years: stood at $8.3 billion in 2022, then decreased by 0.99% to $8.2 billion in 2023, then increased by 7.12% to $8.8 billion in 2024, then grew by 15.18% to $10.1 billion in 2025, then increased by 4.33% to $10.6 billion in 2026.
  • According to Business Quant data, Common Equity over the past three periods came in at $10.6 billion, $10.1 billion, and $10.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.